Metagenomi, Inc. Common Stock
- MGX
- NASDAQ
- Biotechnology
- Gene Editing (Metagenomics)
- Biotech Therapeutics
$0.78
Today −7.24%Quote Oct 16, 2026, 08:00 PM UTC
−30.62%over the last month
Max drawdown −31.8%From 1-month high −31.8%3 months −35.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$29.6M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$14.50
+1749.5% from here
Floor
—
Data unavailable
Where the price sits
5 analysts
Analyst range, low to high
$7.00$22.00
- Price $0.78
- Resistance $0.83
- Consensus $14.50
Analysts' average target sits about 1749% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MGXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
113
Founded
2016